Ajanta Pharma P/B Ratio
Ajanta Pharma (AJANTPHARM) P/B ratio is 9.43 (High), book value per share ₹1810.80 vs Healthcare average P/B of -0.31 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see AJANTPHARM stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
AJANTPHARM P/B Ratio — Valuation Insights & Book Value Analysis
Ajanta Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 9.43 (High). View Ajanta Pharma 52-week for the annual high/low range and current price position.
- Stock appears overvalued with PB of 9.43, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 495.3% above historical average
- Trading at premium to sector average PB of -0.31
Ajanta Pharma P/B Ratio Historical Trend
AJANTPHARM annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Review AJANTPHARM P/E comparison to evaluate earnings-based valuation against sector peers.
AJANTPHARM Historical P/B Ratio — Book Value Per Share & Year-End Price
Ajanta Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.86 | ₹1810.8 | ₹3369.50 | ₹4,527 | Moderate |
| 2025 | 1.83 | ₹1516.0 | ₹2768.90 | ₹3,790 | Moderate |
| 2024 | 2.06 | ₹1426.8 | ₹2932.20 | ₹3,567 | Moderate |
| 2023 | 1.54 | ₹1355.2 | ₹2083.65 | ₹3,388 | Moderate |
| 2022 | 0.63 | ₹1920.0 | ₹1211.95 | ₹3,264 | Low |
AJANTPHARM vs Healthcare Peers — P/B Ratio Comparison
Ajanta Pharma P/B 9.43 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.61 | ₹39 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |